FIELD: biotechnology; medicine.
SUBSTANCE: invention relates to biotechnology, specifically to an antithrombotic molecule having both antiplatelet and anticoagulant (APAC) activity, and can be used in medicine.
EFFECT: obtained molecule consists of human serum albumin and attached multiple heparin chains with masses of 10 to 24 kDa and can be used as anticoagulant or thrombocyte inhibitor.
25 cl, 22 dwg, 3 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| STANDARD DRUG PREPARATIONS AND METHODS OF TREATING THROMBOSIS BY ORAL ADMINISTRATION OF FACTOR XA INHIBITOR | 2007 |
|
RU2452484C2 |
| MODIFIED DNA APTAMERS INHIBITING THROMBIN ACTIVITY | 2009 |
|
RU2410432C1 |
| APTAMER OLIGONUCLEOTIDE - DIRECT THROMBIN INHIBITOR | 2008 |
|
RU2401306C2 |
| THROMBIN DERIVATIVE AND PHARMACEUTICAL FORMULA CONTAINING IT | 2005 |
|
RU2372402C2 |
| ANTITHROMBOSIS AGENT | 1997 |
|
RU2138269C1 |
| ANTITHROMBOTIC COMPLEX BASED ON HEPARIN, METHOD OF ITS PRODUCTION AND USE | 2015 |
|
RU2600817C2 |
| AGENT POSSESSING ANTI-COAGULATING, ANTI-THROMBOCYTIC, ANTI-THROMBOSIS, FIBRIN-DEPOLYMERIZING AND FIBRINOLYTIC ACTIVITY | 2005 |
|
RU2290195C1 |
| ANTITHROMBOTIC COMPOSITION ON BASIS OF HEPARIN FOR PERORAL APPLICATION | 2008 |
|
RU2359681C1 |
| ANTICOAGULANT, ANTIPLATELET AND FIBRIN-DEPOLYMERIZATION COMPLEX BASED ON HEPARIN, METHOD OF ITS PRODUCTION AND USE | 2015 |
|
RU2606836C2 |
| NOVEL COMPOUNDS POSSESSING ANTICOAGULANT FUNCTION, BASED ON THEM PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF THROMBOTIC CONDITIONS AND PLASMA-SUBSTITUTING SOLUTION FOR CORRECTION OF HYPERCOAGULATION DISORDERS IN HEMODILUTION | 2007 |
|
RU2353619C2 |
